market still open for tau antibodies... nature articlehttps://www.nature.com/articles/d41573-020-00217-7
Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating
A wave of tau-targeted agents is progressing through the clinic, hoping to avoid the negative results from a first-in-class trial of a tau-targeted antibody.
I came across this article with an internet search for "Neil Cashman" posted in the last week. The search engine link quotes Dr. Cashman, but I cannot access the article right now.
It appears to be a summary of the ongoing efforts to develop antibodies for tau. I'm trying to find which study the article title is referring to... looks like a PH 1 that did not go well.
Bottom line: more opportunity for ProMIS